Oral fosfomycin for the treatment of chronic bacterial prostatitis

BACKGROUND: Chronic bacterial prostatitis (CBP) is a difficult-to-treat infection as only a few antibiotics achieve therapeutic concentrations in the prostate. Data on the efficacy and safety of oral fosfomycin for the treatment of CBP are limited. OBJECTIVES: To analyse the efficacy and safety of f...

Descripción completa

Detalles Bibliográficos
Autores principales: Karaiskos, Ilias, Galani, Lambrini, Sakka, Vissaria, Gkoufa, Aikaterini, Sopilidis, Odysseas, Chalikopoulos, Dimitrios, Alivizatos, Gerasimos, Giamarellou, Eleni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477975/
https://www.ncbi.nlm.nih.gov/pubmed/30796442
http://dx.doi.org/10.1093/jac/dkz015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477975/
https://www.ncbi.nlm.nih.gov/pubmed/30796442
http://dx.doi.org/10.1093/jac/dkz015

Ejemplares similares